Professor James Tour of Rice University presents a novel molecular robot that was developed thanks to crucial experimental work with Robert Pal of Durham University that targets a specific cell, and then drills into and through the cell wall causing the cell guts to spill out. Preliminary targets are either a cancerous cell or an antibiotic-resistant bacterial cell. The mechanism is rapid cell death via mechanical tearing, not a chemical mechanism, that is highly resistant to both cancer mutations and also antibiotic-resistant bacteria mutations. Neighboring cells are left unaffected.
While this technology is available in vitro now, Professor James Tour expects this technology to be clinically proven and also available to no-option end-oflife patients within 1-5 years, with full approval available in 5-15 years.